Literature DB >> 20480398

APOA1/A5 variants and haplotypes as a risk factor for obesity and better lipid profiles in a Brazilian Elderly Cohort.

Elizabeth Suchi Chen1, Tatiane Katsue Furuya, Diego Robles Mazzotti, Vanessa Kiyomi Ota, Maysa Seabra Cendoroglo, Luiz Roberto Ramos, Lara Quirino Araujo, Rommel Rodriguez Burbano, Marília de Arruda Cardoso Smith.   

Abstract

Genetic variations in the APOA1/C3/A4/A5 gene cluster have been studied and proposed to be the leading key for susceptibility to cardiovascular diseases and age-associated disorders. We aimed to investigate the associations of rs12721026 (APOA1) and rs1729408 (APOA5) polymorphisms and their haplotypes with some age-related diseases, as well as with lipids and proteins serum levels in a cohort from a Brazilian Elderly Longitudinal Study (EPIDOSO). Genotyping was performed by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). Statistical analyses were carried out using logistic regression analysis, Student's t-test, and linkage disequilibrium (LD) analysis. Polymorphic allele frequencies were 0.095 and 0.449 for rs12721026 and rs1729408, respectively. The C-allele of rs1729408 was associated with higher high-density lipoprotein (HDL) (P = 0.022) and glycated hemoglobin levels (P = 0.020). We also showed that rs12721026 and rs1729408 were in LD. The GC haplotype, which is composed of the G-allele of rs12721026 and the C-allele of rs1729408, was significantly associated with obesity (P = 0.028), with higher glycated hemoglobin (P = 0.006), and fasting glucose (P = 0.0003) compared to the TT haplotype, which includes the wild-type alleles of both polymorphisms. Moreover, we found an association between the TC haplotype and higher HDL levels (P = 0.0039). This is the first time that haplotypes involving these polymorphisms were evaluated. Our results showed that these polymorphisms were involved in the development of obesity and in alterations of lipids and proteins serum levels in a Brazilian population. The present findings might also clarify the role of these polymorphisms and their haplotypes in lipids and proteins metabolism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20480398     DOI: 10.1007/s11745-010-3426-z

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  47 in total

1.  LDA--a java-based linkage disequilibrium analyzer.

Authors:  Keyue Ding; Kaixin Zhou; Fuchu He; Yan Shen
Journal:  Bioinformatics       Date:  2003-11-01       Impact factor: 6.937

2.  SNPStats: a web tool for the analysis of association studies.

Authors:  Xavier Solé; Elisabet Guinó; Joan Valls; Raquel Iniesta; Víctor Moreno
Journal:  Bioinformatics       Date:  2006-05-23       Impact factor: 6.937

3.  A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short-term diet.

Authors:  J Aberle; D Evans; F U Beil; U Seedorf
Journal:  Clin Genet       Date:  2005-08       Impact factor: 4.438

4.  Applicability of the CERAD neuropsychological battery to Brazilian elderly.

Authors:  P H Bertolucci; I H Okamoto; S M Brucki; M O Siviero; J Toniolo Neto; L R Ramos
Journal:  Arq Neuropsiquiatr       Date:  2001-09       Impact factor: 1.420

Review 5.  Gene-diet interaction in determining plasma lipid response to dietary intervention.

Authors:  J M Ordovas; J Lopez-Miranda; P Mata; F Perez-Jimenez; A H Lichtenstein; E J Schaefer
Journal:  Atherosclerosis       Date:  1995-12       Impact factor: 5.162

6.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04

7.  Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity.

Authors:  Elizabeth Suchi Chen; Diego Robles Mazzotti; Tatiane Katsue Furuya; Maysa Seabra Cendoroglo; Luiz Roberto Ramos; Lara Quirino Araujo; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  Clin Exp Med       Date:  2009-05-01       Impact factor: 3.984

8.  Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges.

Authors:  Steve Martin; Viviane Nicaud; Steve E Humphries; Philippa J Talmud
Journal:  Biochim Biophys Acta       Date:  2003-04-17

9.  Validity of a Brazilian version of the Older Americans Resources and Services (OARS) mental health screening questionnaire.

Authors:  S L Blay; L R Ramos; J de J Mari
Journal:  J Am Geriatr Soc       Date:  1988-08       Impact factor: 5.562

10.  Restriction fragment length polymorphisms at the apoprotein genes AI, CIII and B-100 and in the 5' flanking region of the insulin gene as possible markers of coronary heart disease.

Authors:  U Wick; E Witt; W Engel
Journal:  Clin Genet       Date:  1995-04       Impact factor: 4.438

View more
  6 in total

Review 1.  Unravelling the effects of the environment and host genotype on the gut microbiome.

Authors:  Aymé Spor; Omry Koren; Ruth Ley
Journal:  Nat Rev Microbiol       Date:  2011-04       Impact factor: 60.633

Review 2.  The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research.

Authors:  Mahdi Garelnabi; Kenton Lor; Jun Jin; Fei Chai; Nalini Santanam
Journal:  Clin Biochem       Date:  2012-09-19       Impact factor: 3.281

3.  Triglyceride-raising APOA5 genetic variants are associated with obesity and non-HDL-C in Chinese children and adolescents.

Authors:  Wei-Fen Zhu; Chun-Lin Wang; Li Liang; Zheng Shen; Jun-Fen Fu; Pei-Ning Liu; Lan-Qiu Lv; Yi-Min Zhu
Journal:  Lipids Health Dis       Date:  2014-06-05       Impact factor: 3.876

Review 4.  New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.

Authors:  Xin Su; Yi Kong; Dao-Quan Peng
Journal:  Lipids Health Dis       Date:  2018-07-27       Impact factor: 3.876

5.  Multivariate analysis of genomics data to identify potential pleiotropic genes for type 2 diabetes, obesity and dyslipidemia using Meta-CCA and gene-based approach.

Authors:  Yuan-Cheng Chen; Chao Xu; Ji-Gang Zhang; Chun-Ping Zeng; Xia-Fang Wang; Rou Zhou; Xu Lin; Zeng-Xin Ao; Jun-Min Lu; Jie Shen; Hong-Wen Deng
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

6.  Interactions of six SNPs in APOA1 gene and types of obesity on low HDL-C disease in Xinjiang pastoral area of China.

Authors:  Xinping Wang; Jia He; Heng Guo; Lati Mu; Yunhua Hu; Jiaolong Ma; Yizhong Yan; Rulin Ma; Shugang Li; Yusong Ding; Mei Zhang; Qiang Niu; Jiaming Liu; Jingyu Zhang; Shuxia Guo
Journal:  Lipids Health Dis       Date:  2017-10-02       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.